Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence 2024-03-12 20:00
Bowtie partners with CUHK Medical Centre to launch the "Medical Insurance + Wellness" Package 2024-03-12 12:01
Innovating the Future: ISoOR 2024 Annual Meeting Achieves Remarkable Success 2024-03-12 11:57
TFS HealthScience Unveils Asia Pacific Expansion, Elevating Patient Access and Innovation 2024-03-12 10:52
Mowilex Provides Interior and Exterior Paint for Pioneering Bali International Hospital 2024-03-12 10:00
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada 2024-03-12 08:00
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting 2024-03-12 08:00
Cell Impact has received an order worth SEK 18 million in the field of electrolysis 2024-03-12 06:48
Appointment of Dr Darren Patti to Group Chief Operating Officer 2024-03-12 05:44
ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results 2024-03-11 17:00
Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry 2024-03-11 15:20
AI Empowers Surgery: CAIR unveils its latest large multimodality model for surgery 2024-03-11 15:06
Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care 2024-03-11 15:00
Fullerton Health Deepens Commitment to Community Health with Health Hub Clinics in the Heartlands 2024-03-11 14:00
This World Oral Health Day, Sensodyne introduces NEW Triple Action Formula: 'Sensitivity Gum & Enamel' 2024-03-11 13:23
FWD Group completes additional investment in Malaysia; becomes majority shareholder in FWD Takaful Berhad 2024-03-11 11:41
RemeGen Presents Oral Presentation on Evaluation of Its Proprietary Disitamab Vedotin (RC48) for Cervical Cancer at ESGO 2024 2024-03-11 10:36
APPIS 2024: Healthcare Stakeholders Come Together to Prioritize Action for Better Patient Outcomes in Asia Pacific, Middle East, and Africa 2024-03-11 10:00
Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Macau 2024-03-11 09:00
Launch of CMDF Showcase Event to Share Achievements, Promote Chinese Medicine Culture to Public and Remark a New Mileage of Chinese Medicine Development 2024-03-09 18:17
1 73 74 75 76 77 810